Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Samuel Hellman

TitleEmeritus/Emerita, Professor
InstitutionUniversity of Chicago
DepartmentRadiation Oncology
AddressChicago IL 60637
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Pitroda SP, Khodarev NN, Huang L, Uppal A, Wightman SC, Ganai S, Joseph N, Pitt J, Brown M, Forde M, Mangold K, Xue L, Weber C, Segal JP, Kadri S, Stack ME, Khan S, Paty P, Kaul K, Andrade J, White KP, Talamonti M, Posner MC, Hellman S, Weichselbaum RR. Author Correction: Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis. Nat Commun. 2018 11 13; 9(1):4827. PMID: 30425251.
      View in: PubMed
    2. Pitroda SP, Khodarev NN, Huang L, Uppal A, Wightman SC, Ganai S, Joseph N, Pitt J, Brown M, Forde M, Mangold K, Xue L, Weber C, Segal JP, Kadri S, Stack ME, Khan S, Paty P, Kaul K, Andrade J, White KP, Talamonti M, Posner MC, Hellman S, Weichselbaum RR. Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis. Nat Commun. 2018 05 04; 9(1):1793. PMID: 29728604.
      View in: PubMed
    3. Oshima G, Stack ME, Wightman SC, Bryan D, Poli E, Xue L, Skowron KB, Uppal A, Pitroda SP, Huang X, Posner MC, Hellman S, Weichselbaum RR, Khodarev NN. Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones. J Vis Exp. 2016 11 30; (117). PMID: 27929457.
      View in: PubMed
    4. Tefferi A, Kantarjian H, Rajkumar SV, Baker LH, Abkowitz JL, Adamson JW, Advani RH, Allison J, Antman KH, Bast RC, Bennett JM, Benz EJ, Berliner N, Bertino J, Bhatia R, Bhatia S, Bhojwani D, Blanke CD, Bloomfield CD, Bosserman L, Broxmeyer HE, Byrd JC, Cabanillas F, Canellos GP, Chabner BA, Chanan-Khan A, Cheson B, Clarkson B, Cohn SL, Colon-Otero G, Cortes J, Coutre S, Cristofanilli M, Curran WJ, Daley GQ, DeAngelo DJ, Deeg HJ, Einhorn LH, Erba HP, Esteva FJ, Estey E, Fidler IJ, Foran J, Forman S, Freireich E, Fuchs C, George JN, Gertz MA, Giralt S, Golomb H, Greenberg P, Gutterman J, Handin RI, Hellman S, Hoff PM, Hoffman R, Hong WK, Horowitz M, Hortobagyi GN, Hudis C, Issa JP, Johnson BE, Kantoff PW, Kaushansky K, Khayat D, Khuri FR, Kipps TJ, Kripke M, Kyle RA, Larson RA, Lawrence TS, Levine R, Link MP, Lippman SM, Lonial S, Lyman GH, Markman M, Mendelsohn J, Meropol NJ, Messinger Y, Mulvey TM, O'Brien S, Perez-Soler R, Pollock R, Prchal J, Press O, Radich J, Rai K, Rosenberg SA, Rowe JM, Rugo H, Runowicz CD, Sandmaier BM, Saven A, Schafer AI, Schiffer C, Sekeres MA, Silver RT, Siu LL, Steensma DP, Stewart FM, Stock W, Stone R, Storb R, Strong LC, Tallman MS, Thompson M, Ueno NT, Van Etten RA, Vose JM, Wiernik PH, Winer EP, Younes A, Zelenetz AD, LeMaistre CA. In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc. 2015 Aug; 90(8):996-1000. PMID: 26211600.
      View in: PubMed
    5. Oshima G, Wightman SC, Uppal A, Stack ME, Pitroda SP, Oskvarek JJ, Huang X, Posner MC, Hellman S, Weichselbaum RR, Khodarev NN. Imaging of tumor clones with differential liver colonization. Sci Rep. 2015 Jun 22; 5:10946. PMID: 26094901.
      View in: PubMed
    6. Uppal A, Wightman SC, Mallon S, Oshima G, Pitroda SP, Zhang Q, Huang X, Darga TE, Huang L, Andrade J, Liu H, Ferguson MK, Greene GL, Posner MC, Hellman S, Khodarev NN, Weichselbaum RR. 14q32-encoded microRNAs mediate an oligometastatic phenotype. Oncotarget. 2015 Feb 28; 6(6):3540-52. PMID: 25686838.
      View in: PubMed
    7. DeVita VT, Eggermont AM, Hellman S, Kerr DJ. Clinical cancer research: the past, present and the future. Nat Rev Clin Oncol. 2014 Nov; 11(11):663-9. PMID: 25245981.
      View in: PubMed
    8. Hellman S. Learning while caring: medicine's epistemology. J Clin Oncol. 2014 Sep 01; 32(25):2804-8. PMID: 25092776.
      View in: PubMed
    9. Uppal A, Ferguson MK, Posner MC, Hellman S, Khodarev NN, Weichselbaum RR. Towards a molecular basis of oligometastatic disease: potential role of micro-RNAs. Clin Exp Metastasis. 2014 Aug; 31(6):735-48. PMID: 24968866.
      View in: PubMed
    10. Corbin KS, Hellman S, Weichselbaum RR. Extracranial oligometastases: a subset of metastases curable with stereotactic radiotherapy. J Clin Oncol. 2013 Apr 10; 31(11):1384-90. PMID: 23460715.
      View in: PubMed
    11. Lussier YA, Khodarev NN, Regan K, Corbin K, Li H, Ganai S, Khan SA, Gnerlich JL, Gnerlich J, Darga TE, Fan H, Karpenko O, Paty PB, Posner MC, Chmura SJ, Hellman S, Ferguson MK, Weichselbaum RR. Oligo- and polymetastatic progression in lung metastasis(es) patients is associated with specific microRNAs. PLoS One. 2012; 7(12):e50141. PMID: 23251360.
      View in: PubMed
    12. Lussier YA, Xing HR, Salama JK, Khodarev NN, Huang Y, Zhang Q, Khan SA, Yang X, Hasselle MD, Darga TE, Malik R, Fan H, Perakis S, Filippo M, Corbin K, Lee Y, Posner MC, Chmura SJ, Hellman S, Weichselbaum RR. MicroRNA expression characterizes oligometastasis(es). PLoS One. 2011; 6(12):e28650. PMID: 22174856.
      View in: PubMed
    13. Salama JK, Hasselle MD, Chmura SJ, Malik R, Mehta N, Yenice KM, Villaflor VM, Stadler WM, Hoffman PC, Cohen EE, Connell PP, Haraf DJ, Vokes EE, Hellman S, Weichselbaum RR. Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease. Cancer. 2012 Jun 01; 118(11):2962-70. PMID: 22020702.
      View in: PubMed
    14. Weichselbaum RR, Hellman S. Oligometastases revisited. Nat Rev Clin Oncol. 2011 06; 8(6):378-82. PMID: 21423255.
      View in: PubMed
    15. Hellman S. On first looking into Kutcher's "Contested Medicine": ethical tensions in clinical research. Perspect Biol Med. 2010; 53(2):304-14. PMID: 20495265.
      View in: PubMed
    16. Connell PP, Hellman S. Advances in radiotherapy and implications for the next century: a historical perspective. Cancer Res. 2009 Jan 15; 69(2):383-92. PMID: 19147546.
      View in: PubMed
    17. Mauceri HJ, Beckett MA, Liang H, Sutton HG, Pitroda S, Galka E, Efimova E, Darga T, Khodarev NN, King CR, Posner MC, Hellman S, Kufe DW, Weichselbaum RR. Translational strategies exploiting TNF-alpha that sensitize tumors to radiation therapy. Cancer Gene Ther. 2009 Apr; 16(4):373-81. PMID: 18974777.
      View in: PubMed
    18. Salama JK, Chmura SJ, Mehta N, Yenice KM, Stadler WM, Vokes EE, Haraf DJ, Hellman S, Weichselbaum RR. An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease. Clin Cancer Res. 2008 Aug 15; 14(16):5255-9. PMID: 18698045.
      View in: PubMed
    19. Hellman S, Botnick L, Mauch P. Stem-cell biology and cancer therapy: the more things change... J Clin Oncol. 2008 Feb 20; 26(6):821-2. PMID: 18281648.
      View in: PubMed
    20. Jani AB, Hellman S. Early prostate cancer: hedonic prices model of provider-patient interactions and decisions. Int J Radiat Oncol Biol Phys. 2008 Mar 15; 70(4):1158-68. PMID: 17881151.
      View in: PubMed
    21. Hellman S. Unintended consequences. Nat Clin Pract Oncol. 2007 Aug; 4(8):439. PMID: 17657250.
      View in: PubMed
    22. Hellman S. Irwin Freedberg and the changing times of academic medicine. J Invest Dermatol. 2006 Mar; 126(3):525-6. PMID: 16482183.
      View in: PubMed
    23. Hellman S. Evolving paradigms and perceptions of cancer. Nat Clin Pract Oncol. 2005 Dec; 2(12):618-24. PMID: 16341117.
      View in: PubMed
    24. Hellman S. Premise, promise, paradigm and prophesy. Nat Clin Pract Oncol. 2005 Jul; 2(7):325. PMID: 16075785.
      View in: PubMed
    25. Jani AB, Kao J, Heimann R, Hellman S. Hormone therapy and radiotherapy for early prostate cancer: a utility-adjusted number needed to treat (NNT) analysis. Int J Radiat Oncol Biol Phys. 2005 Mar 01; 61(3):687-94. PMID: 15708246.
      View in: PubMed
    26. Hellman S, Weichselbaum RR. Importance of local control in an era of systemic therapy. Nat Clin Pract Oncol. 2005 Feb; 2(2):60-1. PMID: 16264859.
      View in: PubMed
    27. Hellman S. Debunking dogma and developing theses. Eur J Cancer. 2005 Mar; 41(4):489-90. PMID: 15737551.
      View in: PubMed
    28. Mehta N, Mauer AM, Hellman S, Haraf DJ, Cohen EE, Vokes EE, Weichselbaum RR. Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment. Int J Oncol. 2004 Dec; 25(6):1677-83. PMID: 15547705.
      View in: PubMed
    29. Lopez CA, Kimchi ET, Mauceri HJ, Park JO, Mehta N, Murphy KT, Beckett MA, Hellman S, Posner MC, Kufe DW, Weichselbaum RR. Chemoinducible gene therapy: a strategy to enhance doxorubicin antitumor activity. . 2004 Sep; 3(9):1167-75. PMID: 15367711.
      View in: PubMed
    30. Hellman S. Excision margins in high-risk malignant melanoma. N Engl J Med. 2004 May 27; 350(22):2305-6; author reply 2305-6. PMID: 15163784.
      View in: PubMed
    31. Singh R, Hellman S, Heimann R. The natural history of breast carcinoma in the elderly: implications for screening and treatment. Cancer. 2004 May 01; 100(9):1807-13. PMID: 15112260.
      View in: PubMed
    32. Hellman S, Hellman D. Letrozole in breast cancer. N Engl J Med. 2004 Feb 12; 350(7):727-30; author reply 727-30. PMID: 14971060.
      View in: PubMed
    33. Jani AB, Kao J, Hellman S. Hormone therapy adjuvant to external beam radiotherapy for locally advanced prostate carcinoma: a complication-adjusted number-needed-to-treat analysis. Cancer. 2003 Dec 01; 98(11):2351-61. PMID: 14635069.
      View in: PubMed
    34. Bartelink H, Benz C, Cleveland D, Dorn R, Gralow J, Gradishar WJ, Grant K, Heimann R, Hellman S, Hudis C, Kerbel R, Lippman M, Lung J, Posner MC, Steeg P, Vestal R, Weichselbaum RR, Zetter B. Expedition Inspiration Fund for Breast Cancer Research Meeting 2003. Breast Cancer Res Treat. 2003 Jul; 80(2):139-44. PMID: 12908816.
      View in: PubMed
    35. Jani AB, Hellman S. Early prostate cancer: clinical decision-making. Lancet. 2003 Mar 22; 361(9362):1045-53. PMID: 12660074.
      View in: PubMed
    36. Benz C, Clark G, Conzen S, Dorn R, Fuqua S, Gralow J, Greene G, Heimann R, Hellman S, Lippman M, Rosen N, Weiner L. Consensus statement: Expedition Inspiration fund for breast cancer research meeting 2002. Breast Cancer Res Treat. 2003 Mar; 78(1):127-31. PMID: 12611465.
      View in: PubMed
    37. Khodarev NN, Park J, Kataoka Y, Nodzenski E, Hellman S, Roizman B, Weichselbaum RR, Pelizzari CA. Receiver operating characteristic analysis: a general tool for DNA array data filtration and performance estimation. Genomics. 2003 Feb; 81(2):202-9. PMID: 12620398.
      View in: PubMed
    38. Jani AB, Basu A, Heimann R, Hellman S. Sentinel lymph node versus axillary lymph node dissection for early-stage breast carcinoma: a comparison using a utility-adjusted number needed to treat analysis. Cancer. 2003 Jan 15; 97(2):359-66. PMID: 12518360.
      View in: PubMed
    39. Weichselbaum RR, Kufe DW, Hellman S, Rasmussen HS, King CR, Fischer PH, Mauceri HJ. Radiation-induced tumour necrosis factor-alpha expression: clinical application of transcriptional and physical targeting of gene therapy. Lancet Oncol. 2002 Nov; 3(11):665-71. PMID: 12424068.
      View in: PubMed
    40. Park JO, Lopez CA, Gupta VK, Brown CK, Mauceri HJ, Darga TE, Manan A, Hellman S, Posner MC, Kufe DW, Weichselbaum RR. Transcriptional control of viral gene therapy by cisplatin. J Clin Invest. 2002 Aug; 110(3):403-10. PMID: 12163460.
      View in: PubMed
    41. Abdalla I, Basu A, Hellman S. An evidence-based analysis of the management of localized prostate cancer. Cancer J. 2002 Jan-Feb; 8(1):40-6. PMID: 11895202.
      View in: PubMed
    42. Hellman S. Sun Valley summary. Consensus and action items Expedition Inspiration meeting 2000. Breast Cancer Res Treat. 2001 Apr; 66(3):179-82. PMID: 11510688.
      View in: PubMed
    43. Salloum RM, Jaskowiak NT, Mauceri HJ, Seetharam S, Beckett MA, Koons AM, Hari DM, Gupta VK, Reimer C, Kalluri R, Posner MC, Hellman S, Kufe DW, Weichselbaum RR. NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity. Cancer Res. 2000 Dec 15; 60(24):6958-63. PMID: 11156396.
      View in: PubMed
    44. Heimann R, Hellman S. Individual characterisation of the metastatic capacity of human breast carcinoma. Eur J Cancer. 2000 Aug; 36(13 Spec No):1631-9. PMID: 10959049.
      View in: PubMed
    45. Hellman S, Heimann R. The clinical significance of tumor progression: breast cancer as a model. Cancer J. 2000 Apr; 6 Suppl 2:S131-3. PMID: 10803827.
      View in: PubMed
    46. Heimann R, Hellman S. Clinical progression of breast cancer malignant behavior: what to expect and when to expect it. J Clin Oncol. 2000 Feb; 18(3):591-9. PMID: 10653874.
      View in: PubMed
    47. Heimann R, Lan F, McBride R, Hellman S. Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin. Cancer Res. 2000 Jan 15; 60(2):298-304. PMID: 10667580.
      View in: PubMed
    48. Hellman S. The ethical lessons of managed care applied to clinical trials. Cancer Treat Res. 2000; 102:91-8. PMID: 10650483.
      View in: PubMed
    49. Gorski DH, Mauceri HJ, Salloum RM, Gately S, Hellman S, Beckett MA, Sukhatme VP, Soff GA, Kufe DW, Weichselbaum RR. Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin. Cancer Res. 1998 Dec 15; 58(24):5686-9. PMID: 9865723.
      View in: PubMed
    50. Heimann R, Hellman S. Aging, progression, and phenotype in breast cancer. J Clin Oncol. 1998 Aug; 16(8):2686-92. PMID: 9704718.
      View in: PubMed
    51. Heimann R, Ferguson DJ, Hellman S. The relationship between nm23, angiogenesis, and the metastatic proclivity of node-negative breast cancer. Cancer Res. 1998 Jul 01; 58(13):2766-71. PMID: 9661889.
      View in: PubMed
    52. Heimann R, Bradley J, Hellman S. The benefits of mammography are not limited to women of ages older than 50 years. Cancer. 1998 Jun 01; 82(11):2221-6. PMID: 9610702.
      View in: PubMed
    53. Heimann R, Ferguson D, Gray S, Hellman S. Assessment of intratumoral vascularization (angiogenesis) in breast cancer prognosis. Breast Cancer Res Treat. 1998; 52(1-3):147-58. PMID: 10066079.
      View in: PubMed
    54. Vijayakumar S, Vaida F, Weichselbaum R, Hellman S. Race and the Will Rogers phenomenon in prostate cancer. Cancer J Sci Am. 1998 Jan-Feb; 4(1):27-34. PMID: 9467043.
      View in: PubMed
    55. Heimann R, Ferguson D, Recant WM, Hellman S. Breast cancer metastatic phenotype as predicted by histologic tumor markers. Cancer J Sci Am. 1997 Jul-Aug; 3(4):224-9. PMID: 9263628.
      View in: PubMed
    56. Hellman S. Darwin's clinical relevance. Cancer. 1997 Jun 15; 79(12):2275-81. PMID: 9191515.
      View in: PubMed
    57. Heimann R, Ferguson D, Powers C, Suri D, Weichselbaum RR, Hellman S. Race and clinical outcome in breast cancer in a series with long-term follow-up evaluation. J Clin Oncol. 1997 Jun; 15(6):2329-37. PMID: 9196147.
      View in: PubMed
    58. Vijayakumar S, Hellman S. Advances in radiation oncology. Lancet. 1997 May; 349 Suppl 2:SII1-3. PMID: 9164437.
      View in: PubMed
    59. Heimann R, Ferguson D, Powers C, Recant WM, Weichselbaum RR, Hellman S. Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. J Natl Cancer Inst. 1996 Dec 04; 88(23):1764-9. PMID: 8944007.
      View in: PubMed
    60. Quiet CA, Ferguson DJ, Weichselbaum RR, Hellman S. Natural history of node-positive breast cancer: the curability of small cancers with a limited number of positive nodes. J Clin Oncol. 1996 Dec; 14(12):3105-11. PMID: 8955655.
      View in: PubMed
    61. Mauceri HJ, Hanna NN, Wayne JD, Hallahan DE, Hellman S, Weichselbaum RR. Tumor necrosis factor alpha (TNF-alpha) gene therapy targeted by ionizing radiation selectively damages tumor vasculature. Cancer Res. 1996 Oct 01; 56(19):4311-4. PMID: 8813113.
      View in: PubMed
    62. Vijayakumar S, Weichselbaum R, Vaida F, Dale W, Hellman S. Prostate-specific antigen levels in African-Americans correlate with insurance status as an indicator of socioeconomic status. Cancer J Sci Am. 1996 Jul-Aug; 2(4):225-33. PMID: 9166537.
      View in: PubMed
    63. Hellman S, Weichselbaum RR. Radiation oncology. JAMA. 1996 Jun 19; 275(23):1852-3. PMID: 8642748.
      View in: PubMed
    64. Hellman S. Roentgen Centennial Lecture: discovering the past, inventing the future. Int J Radiat Oncol Biol Phys. 1996 Apr 01; 35(1):15-20. PMID: 8641912.
      View in: PubMed
    65. Hellman S. The patient and the public good. Monash Bioeth Rev. 1996 Jan; 15(1):S5-10. PMID: 15810187.
      View in: PubMed
    66. Seung LP, Mauceri HJ, Beckett MA, Hallahan DE, Hellman S, Weichselbaum RR. Genetic radiotherapy overcomes tumor resistance to cytotoxic agents. Cancer Res. 1995 Dec 01; 55(23):5561-5. PMID: 7585635.
      View in: PubMed
    67. Hellman S, Weichselbaum RR. Radiation oncology and the new biology. Cancer J Sci Am. 1995 Sep-Oct; 1(3):174-9. PMID: 9166470.
      View in: PubMed
    68. Hallahan DE, Mauceri HJ, Seung LP, Dunphy EJ, Wayne JD, Hanna NN, Toledano A, Hellman S, Kufe DW, Weichselbaum RR. Spatial and temporal control of gene therapy using ionizing radiation. Nat Med. 1995 Aug; 1(8):786-91. PMID: 7585181.
      View in: PubMed
    69. Hellman S. The patient and the public good. Nat Med. 1995 May; 1(5):400-2. PMID: 7585078.
      View in: PubMed
    70. Quiet CA, Ferguson DJ, Weichselbaum RR, Hellman S. Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up. J Clin Oncol. 1995 May; 13(5):1144-51. PMID: 7738620.
      View in: PubMed
    71. Hellman S. Karnofsky Memorial Lecture. Natural history of small breast cancers. J Clin Oncol. 1994 Oct; 12(10):2229-34. PMID: 7931493.
      View in: PubMed
    72. Hellman S, Weichselbaum RR. Radiation oncology. JAMA. 1994 Jun 01; 271(21):1712-4. PMID: 8182867.
      View in: PubMed
    73. Hellman S. Fin de si├Ęcle medicine. Avoiding the unintended consequences of health care reform. Brookings Rev. 1994; 12(2):12-5. PMID: 10133336.
      View in: PubMed
    74. Hellman S. The end of inevitability, or Frankenstein and the biological revolution. Pharos Alpha Omega Alpha Honor Med Soc. 1994; 57(2):41-3. PMID: 8022875.
      View in: PubMed
    75. Hellman S. Dogma and inquisition in medicine. Breast cancer as a case study. Cancer. 1993 Apr 01; 71(7):2430-3. PMID: 8453567.
      View in: PubMed
    76. Hellman S, Hellman DS. Of mice but not men. Problems of the randomized clinical trial. N Engl J Med. 1991 May 30; 324(22):1585-9. PMID: 2027362.
      View in: PubMed
    77. Hellman S. The intellectual quarantine of American medicine. Acad Med. 1991 May; 66(5):245-8. PMID: 2025350.
      View in: PubMed
    78. Hellman S. Thomas Hodgkin and Hodgkin's disease. Two paradigms appropriate to medicine today. JAMA. 1991 Feb 27; 265(8):1007-10. PMID: 1992194.
      View in: PubMed
    Hellman's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _